"The White House has also said that marijuana rescheduling is not a part of Trump’s drug policy priorities for the first year of his second term—a disappointment for advocates and stakeholders who hoped to see him take speedier action.

Former officials with the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) also recently said that, without proactive advocacy for marijuana rescheduling from Trump personally, the process could stall indefinitely."